Javascript is required to run this page

HB2400

Health insurance; use of drug pricing benchmark value.

Status:
Killed

Chief Patron:
Christopher Head (R)

Session:
2017 Regular Session

Summary

As Introduced. Drug pricing benchmark value.

Requires health insurers and other carriers to utilize the same drug pricing benchmark value to reimburse providers, to charge the sponsor of a health plan, and to develop premiums for a health benefit plan. The measure defines a drug pricing benchmark value as the base price of a prescription drug from which the carrier may deviate for reimbursement purposes. (Less)
  • Bill History

  • 01/18/2017 - House: Presented and ordered printed 17102859D
  • 01/18/2017 - House: Referred to Committee on Commerce and Labor
  • 01/31/2017 - House: Impact statement from SCC (HB2400)
  • 01/31/2017 - House: Tabled in Commerce and Labor